col69 I agree. Where the making of submissions for approval resources (human and money) are limited then it makes sense to priorities those geo locations of most need provided they have a large market size. There are plenty of places that fit that category. The matrix of locations could include those places where the population has a propensity to not be immunized as people who refuse a vaccine may well see VIRALEZE as a sensible shield against infection and so buy it.
- Forums
- ASX - By Stock
- SPL
- Viraleze marketing
Viraleze marketing, page-90
-
-
- There are more pages in this discussion • 80 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
|
|||||
Last
9.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $38.81M |
Open | High | Low | Value | Volume |
9.3¢ | 9.4¢ | 9.3¢ | $64.24K | 690.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 443502 | 9.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.4¢ | 35213 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 443502 | 0.093 |
1 | 50000 | 0.091 |
1 | 10331 | 0.090 |
2 | 41247 | 0.089 |
2 | 116000 | 0.088 |
Price($) | Vol. | No. |
---|---|---|
0.094 | 35213 | 2 |
0.095 | 57000 | 3 |
0.096 | 100000 | 1 |
0.097 | 50309 | 2 |
0.098 | 200000 | 1 |
Last trade - 12.53pm 12/09/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |